Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marieke Begemann

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Journal of Clinical Psychiatry|January 10, 2012
Nonsteroidal anti-inflammatory drugs in schizophrenia: ready for practice or a good start? A meta-analysisIris E Sommer, Lot de Witte, Marieke Begemann, et al.
NPJ Schizophrenia|January 12, 2018
The effect of raloxifene augmentation in men and women with a schizophrenia spectrum disorder: a systematic review and meta-analysisJanna de Boer, Merel Prikken, Wan U Lei, et al.
Scientific Reports|October 1, 2020
Drugs with anti-inflammatory effects to improve outcome of traumatic brain injury: a meta-analysisMarieke Begemann, Mikela Leon, Harm Jan van der Horn, et al.
Psychological Medicine|May 29, 2025
Cumulative exposure to childhood adversity and risk of adult psychosis: a dose-response meta-analysisAidan Flinn, Rebecca Hefferman-Clarke, Sophie Parker, et al.
Schizophrenia Research|April 7, 2024
Response to psychotic experiences: Impact of personality traits on perceived levels of distressAnne Neeltje Scholte-Stalenhoef, Lindy-Lou Boyette, Marieke Begemann, et al.
Psychological Medicine|December 19, 2025
Determinants of changes in self-esteem after remission of first-episode psychosis: A study of associated cross-sectional and longitudinal factorsMarit Hidding, Elise van der Stouwe, Bram-Sieben Rosema, et al.
Schizophrenia Research|October 7, 2025
Association between the exposome score for schizophrenia and functioning in remitted first-episode psychosis: results from the HAMLETT studySterre Kamphuis, Angelo Arias-Magnasco, Shiral Gangadin, et al.
NPJ Schizophrenia|October 27, 2018
Efficacy of different types of cognitive enhancers for patients with schizophrenia: a meta-analysisIgne Sinkeviciute, Marieke Begemann, Merel Prikken, et al.
Schizophrenia Bulletin|July 9, 2020
Hallucinations in Older Adults: A Practical ReviewJohanna C Badcock, Frank Larøi, Karina Kamp, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 15, 2025
Risk of relapse during tapering of antipsychotic medication after a first psychotic episode: association with D2 receptor affinity but not with tapering speedShiral S Gangadin, Franciska de Beer, Ben Wijnen, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Journal of Clinical Psychiatry|January 10, 2012
Nonsteroidal anti-inflammatory drugs in schizophrenia: ready for practice or a good start? A meta-analysisIris E Sommer, Lot de Witte, Marieke Begemann, et al.
NPJ Schizophrenia|January 12, 2018
The effect of raloxifene augmentation in men and women with a schizophrenia spectrum disorder: a systematic review and meta-analysisJanna de Boer, Merel Prikken, Wan U Lei, et al.
Scientific Reports|October 1, 2020
Drugs with anti-inflammatory effects to improve outcome of traumatic brain injury: a meta-analysisMarieke Begemann, Mikela Leon, Harm Jan van der Horn, et al.
Psychological Medicine|May 29, 2025
Cumulative exposure to childhood adversity and risk of adult psychosis: a dose-response meta-analysisAidan Flinn, Rebecca Hefferman-Clarke, Sophie Parker, et al.
Schizophrenia Research|April 7, 2024
Response to psychotic experiences: Impact of personality traits on perceived levels of distressAnne Neeltje Scholte-Stalenhoef, Lindy-Lou Boyette, Marieke Begemann, et al.
Psychological Medicine|December 19, 2025
Determinants of changes in self-esteem after remission of first-episode psychosis: A study of associated cross-sectional and longitudinal factorsMarit Hidding, Elise van der Stouwe, Bram-Sieben Rosema, et al.
Schizophrenia Research|October 7, 2025
Association between the exposome score for schizophrenia and functioning in remitted first-episode psychosis: results from the HAMLETT studySterre Kamphuis, Angelo Arias-Magnasco, Shiral Gangadin, et al.
NPJ Schizophrenia|October 27, 2018
Efficacy of different types of cognitive enhancers for patients with schizophrenia: a meta-analysisIgne Sinkeviciute, Marieke Begemann, Merel Prikken, et al.
Schizophrenia Bulletin|July 9, 2020
Hallucinations in Older Adults: A Practical ReviewJohanna C Badcock, Frank Larøi, Karina Kamp, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 15, 2025
Risk of relapse during tapering of antipsychotic medication after a first psychotic episode: association with D2 receptor affinity but not with tapering speedShiral S Gangadin, Franciska de Beer, Ben Wijnen, et al.
Pageof 2